Education
About Us
Working with TipRanks
Follow Us
Martin Babler Insider Profile
4 Followers
Martin Babler, Director at ZS Pharma, holds 0.00 shares in Principia Biopharma (Ticker: PRNB), holds 0.00 shares in ZS Pharma (Ticker: ZSPH), holds ― shares in Neurogene (Ticker: NGNE).
Martin Babler ZS Pharma (ZSPH)Director
ZS Pharma (ZSPH)
Director
Not Ranked
Martin Babler has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Martin Babler holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Martin Babler
Martin Babler's Trading History
ZS Pharma
Dec 21, 2015
―
Uninformative Sell
90.00K
$0.00
Principia Biopharma
Sep 28, 2020
―
Uninformative Sell
5.86M
$0.00
Neurogene
―
Director
―
―
Prelude Therapeutics
―
Director
―
―
89bio
―
Director
―
―
Alumis Inc.
Jul 01, 2024
Pres., CEO & COB, Director
Uninformative Buy
―
$443.12K
Infinity Pharmaceuticals
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Martin Babler's performance on stock
You May Also Like
Martin Babler insider profile FAQ
What is the percentage of profitable transactions made by Martin Babler?
The percentage of profitable transactions made by Martin Babler is ―.
What is the average return per transaction made by Martin Babler?
The average return per transaction made by Martin Babler is ―.
What stocks does Martin Babler hold?
Martin Babler holds: ZSPH, PRNB, NGNE, PRLD, ETNB, ALMS, INFIQ stocks.
What was Martin Babler’s latest transaction?
Martin Babler latest transaction was an Uninformative Sell of $5.86M.
What was Martin Babler's most profitable transaction?
Martin Babler’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Martin Babler's role in ZS Pharma?
Martin Babler's role in ZS Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.